USC-13400-38579
4 vaccinations
5 coded responses
16 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 980 / WA
- Registered
- 2021-11-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
6AR-56455-45246
Child or adolescent in my care · Female · 2021-11-07
Timeline
-
2021-03-24
Dose 1 — Moderna
-
2021-04-21
Dose 2 — Moderna
-
2021-11-01
Dose 3 — Moderna
-
2021-11-06
Registered in v-safe
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-11-10
- 2021-11-15
- 2021-11-22
-
2021-11-29
Survey response — day 28, dose 3MedDRA: Heavy menstrual bleeding, Menstruation irregular, Vaccine positive rechallenge — Feeling: FairFree text: Unusual changes in mensural cycle. Heavier and more intense symptoms surrounding it. This happens after my 2nd dose as well.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-06
- 2021-12-13
- 2022-02-02
-
2022-05-02
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Non covid coldsMedDRA releases: 2024-11 · check-in free text available
-
2022-05-02
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-03
-
2022-09-16
Dose 4 — Pfizer-BioNTech
-
2022-09-28
Survey response — day 7, dose 4MedDRA: Pregnancy — Feeling: Good · Site: PainFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-09-30
Survey response — day 14, dose 4MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Mild cold, tested negative for covid at this timeMedDRA releases: 2024-11 · check-in free text available
-
2022-09-30
Report sent to call center — day 14, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-03
- 2022-10-03
- 2022-10-14
- 2022-10-28
- 2022-12-18
-
2023-03-17
Survey response — 6 months, dose 4MedDRA: Delivery, Office visit — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-03-17
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2023-03-20
- 2023-03-20
- 2023-03-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Moderna | No |
| 2 | 2021-04-21 | Moderna | No |
| 3 | 2021-11-01 | Moderna | No |
| 4 | 2022-09-16 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-02 | Unsuccessful | |
| 2022-09-30 | Unsuccessful | |
| 2023-03-17 | Unsuccessful |
Free text
Release 10 — day 28, dose 3
Symptoms: Unusual changes in mensural cycle. Heavier and more intense symptoms surrounding it. This happens after my 2nd dose as well.
Release 11 — 6 months, dose 3
Symptoms: Non covid colds
Release 12 — day 7, dose 4
Systemic reaction (other): Pregnancy
Release 12 — day 14, dose 4
Symptoms: Mild cold, tested negative for covid at this time
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Vaccine positive rechallenge | · | · | ✓ |
| SRO | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release